OSUR OraSure Technologies, Inc. Stock Quote

OSUR [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-0.07	Insider Own	1.00%	Shs Outstand	71.76M	Perf Week	3.84%
Market Cap	697.54M	Forward P/E	17.82	EPS next Y	0.55	Insider Trans	-1.38%	Shs Float	70.57M	Perf Month	-6.62%
Income	-3.80M	PEG	-	EPS next Q	0.05	Inst Own	97.30%	Short Float	9.09%	Perf Quarter	-32.01%
Sales	198.70M	P/S	3.51	EPS this Y	-182.50%	Inst Trans	0.41%	Short Ratio	5.50	Perf Half Y	-23.02%
Book/sh	5.55	P/B	1.75	EPS next Y	-2.15%	ROA	-3.50%	Target Price	17.00	Perf Year	-42.29%
Cash/sh	2.92	P/C	3.33	EPS next 5Y	20.00%	ROE	-3.90%	52W Range	8.58 - 19.75	Perf YTD	-8.08%
Dividend	-	P/FCF	-	EPS past 5Y	-28.80%	ROI	-4.10%	52W High	-50.73%	Beta	-0.25
Dividend %	-	Quick Ratio	5.50	Sales past 5Y	7.50%	Gross Margin	62.40%	52W Low	13.40%	ATR	0.47
Employees	570	Current Ratio	6.20	Sales Q/Q	26.60%	Oper. Margin	-4.50%	RSI (14)	47.42	Volatility	6.42% 4.75%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-33.90%	Profit Margin	-7.20%	Rel Volume	0.91	Prev Close	9.86
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	1.17M	Price	9.73
Recom	2.30	SMA20	0.88%	SMA50	-6.30%	SMA200	-22.34%	Volume	1,046,257	Change	-1.32%

Aug-21-20

Initiated

Evercore ISI

Outperform

$22

Aug-10-20

Initiated

JP Morgan

Neutral

$18

Aug-10-20

Initiated

Citigroup

Buy

$18

Aug-07-20

Upgrade

Raymond James

Mkt Perform → Outperform

$16

Jun-25-20

Initiated

Lake Street

Buy

$19

Apr-21-20

Resumed

Stephens

Equal-Weight

$14

Oct-23-18

Resumed

Raymond James

Mkt Perform

Jul-16-18

Downgrade

Stephens

Overweight → Equal-Weight

Nov-02-17

Downgrade

Jefferies

Buy → Hold

Feb-09-17

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-13-16

Downgrade

Raymond James

Outperform → Mkt Perform

Nov-05-15

Reiterated

Mizuho

Buy

$12 → $8

May-07-15

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Jan-23-15

Reiterated

Mizuho

Buy

$10 → $12

Jun-12-14

Reiterated

Canaccord Genuity

Buy

$10 → $11

Jun-11-14

Reiterated

Mizuho

Buy

$9 → $10

Dec-21-12

Initiated

Mizuho

Buy

Aug-08-12

Upgrade

Barrington Research

Mkt Perform → Outperform

$12.50

Jul-05-12

Downgrade

Barrington Research

Outperform → Mkt Perform

Mar-27-12

Initiated

JMP Securities

Mkt Outperform

$15

May-10-21 06:00AM	Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV GlobeNewswire
May-06-21 01:01AM	Orasure Technologies Inc (OSUR) Q1 2021 Earnings Call Transcript Motley Fool +7.87%
May-05-21 05:25PM	OraSure Technologies (OSUR) Beats Q1 Earnings and Revenue Estimates Zacks
04:00PM	OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
09:47AM	If You Had Bought OraSure Technologies' (NASDAQ:OSUR) Shares A Year Ago You Would Be Down 40% Simply Wall St.
Apr-30-21 04:01PM	OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET GlobeNewswire
Apr-28-21 12:34PM	OraSure Technologies (OSUR) Earnings Expected to Grow: What to Know Ahead of Q1 Release Zacks
Mar-30-21 07:00AM	OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization GlobeNewswire
Mar-10-21 10:29AM	Raymond James: These 3 Stocks Are Poised to Surge by at Least 50% TipRanks
Mar-01-21 08:31PM	Orasure Technologies Inc (OSUR) Q4 2020 Earnings Call Transcript Motley Fool
06:45PM	OraSure Technologies (OSUR) Q4 Earnings Miss Estimates Zacks
04:49PM	Recap: OraSure Technologies Q4 Earnings Benzinga
04:15PM	OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
Feb-26-21 10:09AM	OraSure Technologies's Earnings: A Preview Benzinga
Feb-24-21 04:01PM	OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference GlobeNewswire +5.14%
Feb-18-21 06:00AM	2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET GlobeNewswire
Feb-10-21 12:31PM	OraSure Technologies (OSUR) to Report Q4 Results: Wall Street Expects Earnings Growth Zacks
Jan-29-21 06:00AM	OraSure Subsidiary DNA Genoteks OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test GlobeNewswire
Jan-28-21 08:02AM	Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging Zacks
06:00AM	OraSure Subsidiary DNA Genoteks OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing GlobeNewswire
Jan-27-21 08:55AM	Allscripts (MDRX) Extends Tie-Up With US Orthopedic Alliance Zacks
Jan-26-21 07:57AM	OraSures OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government Test to Release for International Travel COVID-19 Testing Program GlobeNewswire
Jan-25-21 06:00AM	Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigens Scientific Advisory Board GlobeNewswire
Jan-21-21 09:46AM	Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout Zacks
06:00AM	OraSures Oragene®Dx Saliva Collection Kit Included in Industrys First FDA Authorization for a Whole Exome Sequencing Platform GlobeNewswire
Jan-14-21 08:34AM	Aphria (APHA) Looks Good: Stock Adds 6% in Session Zacks
Jan-08-21 06:00AM	OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire
Jan-05-21 06:00AM	OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire +6.60%
Dec-23-20 06:00AM	OraSures OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test GlobeNewswire
Dec-21-20 04:01PM	OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test GlobeNewswire +5.50%
Nov-30-20 07:00AM	OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference GlobeNewswire
07:00AM	OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell GlobeNewswire
Nov-12-20 07:00AM	OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 GlobeNewswire
Nov-09-20 03:52PM	Stock Upgrades: Orasure Technologies Shows Rising Relative Strength Investor's Business Daily
08:02AM	Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers PR Newswire
Nov-06-20 08:59AM	OraSure Technologies, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St. +5.30%
Nov-04-20 06:05PM	OraSure Technologies (OSUR) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM	OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments GlobeNewswire
03:15PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE
Nov-03-20 07:00AM	OraSures DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2 GlobeNewswire
Oct-28-20 12:32PM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-21-20 06:00AM	OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call Wednesday, November 4, 2020, 5:00 p.m. ET GlobeNewswire -5.62%
Oct-20-20 10:17AM	Company News for Oct 20, 2020 Zacks -7.34%
Oct-19-20 11:44AM	Why OraSure Technologies Stock Is Soaring Today Motley Fool +15.42%
10:28AM	Return On Capital Employed Overview: OraSure Technologies Benzinga
06:00AM	OraSures OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 GlobeNewswire
Oct-08-20 08:51AM	Implied Volatility Surging for OraSure (OSUR) Stock Options Zacks
Oct-05-20 12:23PM	Hedge Funds Are Crazy About OraSure Technologies, Inc. (OSUR) Insider Monkey +8.01%
Sep-24-20 06:00AM	OraSures ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test GlobeNewswire -8.31%
Sep-15-20 12:00PM	Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing GlobeNewswire
Sep-03-20 04:30PM	OraSures ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test GlobeNewswire -5.46%
Aug-27-20 04:30PM	OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire -19.99%
Aug-21-20 09:32AM	Benzinga's Top Upgrades, Downgrades For August 21, 2020 Benzinga +12.09%
Aug-11-20 12:39PM	Here's What OraSure Technologies, Inc.'s (NASDAQ:OSUR) Shareholder Ownership Structure Looks Like Simply Wall St. -7.84%
12:38PM	Is OraSure Technologies, Inc. (NASDAQ:OSUR) Popular Amongst Institutions? Simply Wall St.
Aug-05-20 07:15PM	OraSure Technologies (OSUR) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:01PM	OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs GlobeNewswire
Aug-04-20 10:59AM	Did Hedge Funds Make The Right Call On OraSure Technologies, Inc. (OSUR) ? Insider Monkey
Jul-31-20 12:15PM	OraSures OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test GlobeNewswire
11:23AM	Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test PR Newswire
Jul-29-20 12:33PM	Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline Zacks
Jul-22-20 06:00AM	OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020 GlobeNewswire
Jun-25-20 08:00AM	Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study GlobeNewswire +6.71%
Jun-23-20 12:52PM	Hedge Funds Warming Up To OraSure Technologies, Inc. (OSUR) Insider Monkey
Jun-17-20 07:00AM	OraSures DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomics GlobeNewswire
07:00AM	Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics PR Newswire
Jun-16-20 08:21AM	Edited Transcript of OSUR.OQ earnings conference call or presentation 6-May-20 9:00pm GMT Thomson Reuters StreetEvents
Jun-10-20 08:00AM	OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples GlobeNewswire
Jun-08-20 08:00AM	OraSures Oragene®Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test GlobeNewswire
Jun-03-20 08:50PM	OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock GlobeNewswire -7.02%
Jun-02-20 11:15PM	OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock GlobeNewswire -14.24%
Jun-01-20 04:01PM	OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
May-29-20 07:00AM	OraSure Technologies, Inc. Announces Purchase of UrSure, Inc. GlobeNewswire +7.62%
06:00AM	OraSure Technologies Appoints Lelio Marmora to Board of Directors GlobeNewswire
May-26-20 06:00AM	OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference GlobeNewswire
May-22-20 07:00AM	OraSures OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test GlobeNewswire
06:00AM	Diversigen Inc. Selected by Nom Nom as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services GlobeNewswire
May-15-20 06:00AM	OraSure Technologies to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-14-20 06:00AM	OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 19, 2020 GlobeNewswire
May-12-20 08:00AM	OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries GlobeNewswire
May-07-20 10:31AM	OraSure Technologies (OSUR) Q1 2020 Earnings Call Transcript Motley Fool
May-06-20 04:00PM	OraSure Announces 2020 First Quarter Financial Results and Provides COVID-19 Update GlobeNewswire +5.17%
May-05-20 06:00AM	OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit Lead GlobeNewswire
May-04-20 06:00AM	DNA Genoteks ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test GlobeNewswire
May-02-20 10:56AM	Can You Imagine How Jubilant OraSure Technologies' (NASDAQ:OSUR) Shareholders Feel About Its 173% Share Price Gain? Simply Wall St.
Apr-29-20 12:33PM	Earnings Preview: OraSure Technologies (OSUR) Q1 Earnings Expected to Decline Zacks
Apr-09-20 06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Apr-08-20 01:18PM	Lehigh Valley medical device company working on at-home COVID-19 test American City Business Journals
06:00AM	OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors GlobeNewswire
Apr-06-20 06:00AM	OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test GlobeNewswire +7.76%
Apr-02-20 09:35AM	OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher Zacks -9.50%
Mar-27-20 07:20AM	What Is OraSure Technologies's (NASDAQ:OSUR) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Mar-19-20 09:17AM	Should OraSure Technologies, Inc. (NASDAQ:OSUR) Focus On Improving This Fundamental Metric? Simply Wall St. +6.19%
Feb-26-20 06:00AM	OraSure Technologies to Present at the Raymond James 41st Annual Institutional Investors Conference GlobeNewswire
01:09AM	Edited Transcript of OSUR earnings conference call or presentation 19-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-21-20 10:04AM	Earnings Miss: OraSure Technologies, Inc. Missed EPS By 10.0% And Analysts Are Revising Their Forecasts Simply Wall St.
07:46AM	The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
Feb-20-20 07:06AM	The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study Benzinga -13.90%

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company offers ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbime, and animal genetics markets. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weber Kathleen Gallagher	EVP & BU Lead - Molecular	Dec 23	Sale	11.76	10,000	117,600	96,544	Jan 04 05:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience